Researchers Further Define Sources of Adult Blood Stem Cells

The Faculty of 1000 is aWeb-based literature awareness tool published by BioMed Central. For more information visit www.facultyof1000.com. Although controversial fetal stem cells hog the limelight, hematopoietic stem cells (HSCs), which give rise to the entire adult blood system, quietly facilitate high-dose chemotherapy on a regular basis in hospitals worldwide. But HSCs have not been without intrigue--whence they come and how they arise in early development remains mysterious. Now, two colla

Written byMignon Fogarty
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Although controversial fetal stem cells hog the limelight, hematopoietic stem cells (HSCs), which give rise to the entire adult blood system, quietly facilitate high-dose chemotherapy on a regular basis in hospitals worldwide. But HSCs have not been without intrigue--whence they come and how they arise in early development remains mysterious. Now, two collaborating labs have produced papers that place the camera's glare directly on the embryonic origins of adult HSCs.1,2

Professor Elaine Dzierzak, Department of Cell Biology and Genetics, Erasmus University, Rotterdam, first realized that embryonic HSCs have two different origins.3 "The work really started about 10 years ago when we were looking at where the first stem cells for the adult blood system come from," says Dzierzak. "We found this area within the body of the embryo, which we call the AGM region, [aorta-gonad-mesonephros] where the first hematopoietic stem cells are generated." Prior to this discovery, she says, scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies